- Home
- KYMR vs BBUC Comparison
KYMR vs BBUC Comparison
Compare KYMR & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- BBUC
- Stock Information
- Founded
- KYMR 2015
- BBUC 2022
- Country
- KYMR United States
- BBUC United States
- Employees
- KYMR N/A
- BBUC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- BBUC
- Sector
- KYMR Health Care
- BBUC
- Exchange
- KYMR Nasdaq
- BBUC Nasdaq
- Market Cap
- KYMR 1.8B
- BBUC 1.7B
- IPO Year
- KYMR 2020
- BBUC N/A
- Fundamental
- Price
- KYMR $45.87
- BBUC $29.50
- Analyst Decision
- KYMR Strong Buy
- BBUC
- Analyst Count
- KYMR 16
- BBUC 0
- Target Price
- KYMR $59.38
- BBUC N/A
- AVG Volume (30 Days)
- KYMR 1.1M
- BBUC 75.0K
- Earning Date
- KYMR 08-06-2025
- BBUC 01-01-0001
- Dividend Yield
- KYMR N/A
- BBUC 0.89%
- EPS Growth
- KYMR N/A
- BBUC N/A
- EPS
- KYMR N/A
- BBUC N/A
- Revenue
- KYMR $58,885,000.00
- BBUC $8,309,000,000.00
- Revenue This Year
- KYMR $43.38
- BBUC N/A
- Revenue Next Year
- KYMR $10.97
- BBUC N/A
- P/E Ratio
- KYMR N/A
- BBUC N/A
- Revenue Growth
- KYMR N/A
- BBUC 8.15
- 52 Week Low
- KYMR $19.45
- BBUC $18.21
- 52 Week High
- KYMR $53.27
- BBUC $30.14
- Technical
- Relative Strength Index (RSI)
- KYMR 67.58
- BBUC 61.88
- Support Level
- KYMR $45.80
- BBUC $27.81
- Resistance Level
- KYMR $47.51
- BBUC $28.60
- Average True Range (ATR)
- KYMR 2.86
- BBUC 0.71
- MACD
- KYMR -0.03
- BBUC -0.10
- Stochastic Oscillator
- KYMR 67.19
- BBUC 73.09
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.